C07C43/12

Electrolytic solution, electrochemical device, lithium-ion secondary cell, and module

The present invention provides an electrolytic solution capable of providing an electrochemical device (e.g., a lithium ion secondary battery) or a module that is less likely to generate gas even in high-temperature storage and has high capacity retention even after high-temperature storage. The present invention relates to an electrolytic solution which may contain a compound represented by Y.sup.21R.sup.21CCY.sup.22R.sup.22 wherein R.sup.21 and R.sup.22 may be the same as or different from each other, and are each H, an alkyl group, or a halogenated alkyl group; Y.sup.21 and Y.sup.22 may be the same as or different from each other, and are each OR.sup.23 or a halogen atom; and R.sup.23 is H, an alkyl group, or a halogenated alkyl group.

Production method for 1,2,2,2-tetrafluoroethyl difluoromethyl ether (desflurane)

Fluoral is obtained by gas-phase fluorination of chloral in the presence of a catalyst and then reacted with trimethyl orthoformate, thereby readily forming 1,2,2,2-tetrafluoroethyl methyl ether as an intermediate for production of desflurane. 1,2,2,2-Tetrafluoroethyl difluoromethyl ether (desflurane) is produced with high yield from the thus-formed 1,2,2,2-tetrafluoroethyl methyl ether by chlorination and fluorination. This method enables efficient industrial-scale production of desflurane useful as an inhalation anesthetic.

Production method for 1,2,2,2-tetrafluoroethyl difluoromethyl ether (desflurane)

Fluoral is obtained by gas-phase fluorination of chloral in the presence of a catalyst and then reacted with trimethyl orthoformate, thereby readily forming 1,2,2,2-tetrafluoroethyl methyl ether as an intermediate for production of desflurane. 1,2,2,2-Tetrafluoroethyl difluoromethyl ether (desflurane) is produced with high yield from the thus-formed 1,2,2,2-tetrafluoroethyl methyl ether by chlorination and fluorination. This method enables efficient industrial-scale production of desflurane useful as an inhalation anesthetic.

Solvent composition, cleaning method, coating film-forming composition, and method of forming a coating film

There are provided a solvent composition containing tDCE, which does not exert an adverse effect on the global environment, has high solubility and incombustibility, and can maintain initial incombustibility even in use accompanied by a phase change, a cleaning method using the solvent composition, a coating film-forming composition including the solvent composition, and a method of forming a homogeneous coating film using the coating film-forming composition. A solvent composition includes: tDCE; at least one HFE (A) selected from HFE-347pc-f, HFE-365mf-c, and HFE-467sc-f; and at least one HFC (X) selected from cHFC-447, and HFC-76-13sf, in which a ratio of tDCE with respect to a total amount of tDCE, HFE (A), and HFC (X) is 65 to 80 mass %, a ratio of HFE (A) with respect to the total amount is 5 to 25 mass %, and a ratio of HFC (X) with respect to the total amount is 5 to 25 mass %.

FLUORINATED ETHER COMPOUND, FLUORINATED ETHER COMPOSITION, COATING LIQUID, ARTICLE AND ITS PRODUCTION METHOD
20200071251 · 2020-03-05 · ·

To provide a fluorinated ether compound capable of forming a surface layer excellent in initial water/oil repellency, fingerprint stain removability, abrasion resistance and light resistance; a fluorinated ether composition and a coating liquid containing the fluorinated ether compound; an article having a surface layer excellent in initial water/oil repellency, fingerprint stain removability, abrasion resistance and light resistance and a method for producing it. A fluorinated ether compound having a poly(oxyperfluoroalkylene) chain having a unit () which is an oxyperfluoroalkylene unit having 5 or 6 carbon atoms, and a unit () which is an oxyperfluoroalkylene unit having at most 4 carbon atoms, and having at least one of a hydrolysable silyl group and a silanol group on at least one terminal of the poly(oxyperfluoroalkylene) chain via a linking group.

QUANTUM DOTS WITH STABILIZING FLUOROCHEMICAL AGENTS

Disclosed are quantum dots and quantum dot articles stabilized by a stabilizing agent of the formula:

##STR00001##

QUANTUM DOTS WITH STABILIZING FLUOROCHEMICAL AGENTS

Disclosed are quantum dots and quantum dot articles stabilized by a stabilizing agent of the formula:

##STR00001##

Production Method for Halogenated Alpha-Fluoroethers
20190352246 · 2019-11-21 ·

A halogenated ca-fluoroether of the formula (2) (where HaloR represents haloalkyl; R.sup.1 represents hydrogen, halogen, alkyl or substituted alkyl; and R.sup.2 represents alkyl or substituted alkyl) is produced efficiently on an industrial scale by reacting a halogenated aldehyde of the formula (1) (where HaloR represents haloalkyl) or an equivalent thereof with hydrogen fluoride.

##STR00001##

Production Method for Halogenated Alpha-Fluoroethers
20190352246 · 2019-11-21 ·

A halogenated ca-fluoroether of the formula (2) (where HaloR represents haloalkyl; R.sup.1 represents hydrogen, halogen, alkyl or substituted alkyl; and R.sup.2 represents alkyl or substituted alkyl) is produced efficiently on an industrial scale by reacting a halogenated aldehyde of the formula (1) (where HaloR represents haloalkyl) or an equivalent thereof with hydrogen fluoride.

##STR00001##

Production Method for 1,2,2,2-Tetrafluoroethyl Difluoromethyl Ether (Desflurane)

Fluoral is obtained by gas-phase fluorination of chloral in the presence of a catalyst and then reacted with trimethyl orthoformate, thereby readily forming 1,2,2,2-tetrafluoroethyl methyl ether as an intermediate for production of desflurane. 1,2,2,2-Tetrafluoroethyl difluoromethyl ether (desflurane) is produced with high yield from the thus-formed 1,2,2,2-tetrafluoroethyl methyl ether by chlorination and fluorination. This method enables efficient industrial-scale production of desflurane useful as an inhalation anesthetic